Olema Oncology to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference

Rhea-AI Summary

Olema Pharmaceuticals (NASDAQ: OLMA) announced that its CEO, Sean P. Bohen, will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 11, 2021, at 10 a.m. ET. The presentation will be available for live streaming, and a replay will be provided thereafter. Olema is focused on developing targeted therapies for women's cancers, with its lead candidate, OP-1250, being evaluated for ER-positive breast cancer in a Phase 1/2 trial.

SAN FRANCISCO, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” NASDAQ: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers, today announced that Sean P. Bohen, M.D., Ph.D., president and chief executive officer, will present at the 39^th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021, at 10 a.m. Eastern Time.

The presentation and Q&A session will be webcast live from the Investors & Media section of Olema’s website. A replay of the webcast will be available.

About Olema Oncology
Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer. Olema is headquartered in San Francisco.

Contacts
Investor Contact:
ir@olema.com

Media Contact:
Sheryl Seapy, W2O
sseapy@w2ogroup.com
949-903-4750

FAQ

When is Olema Pharmaceuticals presenting at the J.P. Morgan Virtual Healthcare Conference?

Olema Pharmaceuticals will present on January 11, 2021, at 10 a.m. ET.

Who will present for Olema at the 39th Annual J.P. Morgan Virtual Healthcare Conference?

Sean P. Bohen, the CEO of Olema Pharmaceuticals, will present at the conference.

What is the focus of Olema Pharmaceuticals?

Olema Pharmaceuticals focuses on the discovery and development of targeted therapies for women's cancers.

What is Olema's lead product candidate?

Olema's lead candidate is OP-1250, which is being tested for ER-positive breast cancer.

Where can I access the webcast of Olema's presentation?

The presentation can be accessed via the Investors & Media section on Olema's website.